ORI — Orion Nutraceuticals Cashflow Statement
0.000.00%
HealthcareMicro Cap
Annual cashflow statement for Orion Nutraceuticals, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.386 | -0.883 | -2.62 | -0.28 | -0.062 |
| Non-Cash Items | -0.155 | 0.341 | 2.34 | 0.001 | -0.255 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.494 | -0.393 | 0.195 | 0.227 | 0.259 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Cash from Operating Activities | -0.048 | -0.935 | -0.083 | -0.052 | -0.057 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -2.4 | -0.188 | 0 | 0.255 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -2.4 | -0.188 | 0 | 0.255 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.544 | 3.11 | 0 | 0.046 | -0.008 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.496 | -0.221 | -0.271 | -0.005 | 0.189 |